Updated: 2011-05-29 22:12:39
Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2011-05-28 22:07:46
: Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2011-05-24 05:01:28
(Beyond Pesticides, May 24, 2011) Last Friday, the U.S. Court of Appeals for the Ninth Circuit issued a summary order upholding a landmark legal decision requiring the U.S. Department of Agriculture (USDA) to conduct an Environmental Impact Statement (EIS) before approving the planting of genetically engineered (GE) crops. The decision upholds previous court rulings in [...]
Updated: 2011-05-21 15:34:23
: Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2011-05-19 05:01:13
(Beyond Pesticides, May 19, 2011) Scientists at the University of Sherbrooke in Quebec, Canada found that pesticides associated with genetically engineered (GE) foods are present in maternal, fetal and nonpregnant women’s blood, emphasizing the need for further research into the effects that GE food has on human health. The study, “Maternal and fetal exposure to [...]
Updated: 2011-05-16 23:36:39
: Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2011-05-12 07:03:15
One problem with gene therapy is how to deliver the genes. The immune system will react to gene carrier packages, the liver potentially could filter out the gene therapy packages, and genes usually should go to only a small number of cell types and organs Packaging gene therapy into microbubbles enables better control and success for delivering gene therapy into cancer cells in prostates. Richmond, Va. (May 10, 2011) Cancer researchers are a step closer to finding a cure for advanced prostate cancer after effectively combining an anti-cancer drug with a viral gene therapy in vivo using novel ultrasound-targeted microbubble-destruction (UTMD) technology. The research was conducted by scientists at Virginia Commonwealth University Massey Cancer Center, VCU Institute of Molecular...
Updated: 2011-05-11 16:56:52
Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2011-05-11 16:56:51
Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2011-05-11 16:56:51
Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2011-05-10 16:52:18
: Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2011-05-09 18:27:53
: Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2011-05-03 04:31:10
Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products